Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?

Terns carries a Zacks Rank #2 (Buy) at present. A couple of other top-ranked stocks in the biotech sector are Ligand Pharmaceuticals (LGND) and ALX Oncology Holdings (ALXO) , each carrying a Zacks Rank #2 at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. In the past 30 days, the Zacks Consensus Estimate for Ligand's 2024 earnings per share (EPS) has increased 16 cents to $4.71. During the same time frame, the consensus estimate for 2025 EPS has increased 70 cents t ...